The role of bispecific antibodies in the treatment of patients with ...

Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, Miami, FL, gives an overview of the role of bispecific antibodies in the ...

The role of bispecific antibodies in the treatment of ... - YouTube

The role of bispecific antibodies in the treatment of patients with multiple myeloma · VJHemOnc – Video Journal of Hematology & HemOnc.

Bispecific antibodies in the treatment of multiple myeloma - Nature

Engaging immune T cells for tumour cell kill with chimeric antigenic T-cell (CAR T-cell) therapy and bispecific antibodies have become important ...

Dr Awan on the Evolving Role of Bispecific Antibodies Treatment in ...

Initially introduced for patients in the third-line setting or those who were ineligible for CAR T-cell therapy, bispecific antibodies have ...

The Role of Bispecific Antibodies in Relapsed Refractory Multiple ...

Multiple myeloma is a heterogeneous clonal malignant plasma cell disorder, which remains incurable despite the therapeutic armamentarium's ...

Bispecific Antibodies: An Area of Research and Clinical Applications

BsAbs have joined mAbs on the therapeutic antibody stage. By targeting two antigens or epitopes, they can cause multiple physiological or anti- ...

The role of bispecific antibodies in the treatment landscape for R/R ...

So bispecific antibodies are allowing the patient's own T-cells to cause tumor cell death, in a rapid fashion because they are off-the-shelf ...

Bispecific antibodies in cancer therapy: Target selection and ...

In oncology therapy, monoclonal antibody drugs have demonstrated excellent therapeutic effects, such as Rituximab (anti-CD20) and Trastuzumab (anti-HER2), which ...

Bispecific antibodies for the treatment of B-cell lymphoma

Anti-CD20xCD3 BsAb have demonstrated remarkable single-agent activity in patients with heavily pretreated B-NHL with a manageable toxicity ...

Usmani Highlights the Role of Bispecific Antibodies in Relapsed ...

Between October 25, 2022, and August 14, 2023, the FDA approved 3 bispecific antibodies for the treatment of patients with relapsed/refractory ...

Bispecific Antibody Use in Patients With Lymphoma and Multiple ...

Part II: Toxicity Management. The current FDA-approved BsAbs for patients with relapsed or refractory multiple myeloma (RRMM) after four or more ...

Understanding the Role of Bispecific Antibodies in the Management ...

Advancements in antibody construct design along with improved safety profile and clinical effectiveness of the most recent BsAbs suggest that ...

The role of bispecific antibodies in the treatment landscape for R/R ...

The role of bispecific antibodies in the treatment landscape for R/R DLBCL ; The benefits of bispecific antibodies over CAR-T cell therapy in ...

Bispecific antibodies: advancing precision oncology: Trends in Cancer

The toxicities associated with the use of bsAbs need bespoke management strategies and expertise in clinical use. Understanding mechanisms of ...

Best Practices in Expanding Access to Bispecific Antibodies and ...

Bispecific antibodies are an emerging class of novel immunotherapy agents with tremendous treatment potential. With more than 50 bispecific antibodies ...

Bispecific Antibodies: What They Are & How They Treat Cancer

Bispecific antibodies are a form of immunotherapy that may allow the body to target and destroy cancer cells. Learn about this treatment and ...

The promise of bispecific antibodies: Clinical applications and ...

Bispecific antibodies (BsAbs) are emerging therapeutic option in cancer patients. · BsAbs have unique formats to achieve their proposed function and clinical ...

Bispecific Therapies | International Myeloma Foundation

Bispecific Antibodies (also known as bispecifics, or BsAbs) · Patients who may not be eligible for CAR T-cell therapy may be eligible for bispecific therapies.

Bispecific antibody - AstraZeneca

One area of emerging significance is the potential value of bispecific antibodies in the treatment of refractory or resistant forms of cancer, a growing ...

Bispecific Antibodies for Multiple Myeloma: Six Things Your Patients ...

Antibodies are Y-shaped proteins that play a key role in the immune system. Produced in the millions, they're each able to latch onto a ...